(no subject)
Jun. 10th, 2020 10:26 am![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png){kind=small}
timeletsSINGAPORE - Singapore will embark on human clinical trials next week on 23 healthy individuals for a potential treatment for Covid-19.
The phase one trial, developed by Singapore-based biotechnology company Tychan, will be conducted by the SingHealth Investigational Medicine Unit and take about six weeks.
It is meant to determine the safety and effectiveness of TY027, a monoclonal antibody or immune system protein that specifically targets Sars-CoV-2, the virus that causes Covid-19, said Tychan in a statement on Wednesday (June 10).
https://www.straitstimes.com/singapore/singapore-to-start-clinical-trials-for-potential-covid-19-treatment
